Secondary outcomes
ciliochoroidal detachment, hyphema, Hyphema, glaucoma
HYPHEMA, POSTOPERATIVE COMPLICATIONS, HYPHEMA, GLAUCOMA, ANTERIOR CHAMBER INFLAMMATION, MACULAR EDEMA
Secondary outcomes were the rate of IOP changes from the preoperative IOPs, flare values, corneal ECDs, the number of glaucoma medications, the usage rate per glaucoma medication type, and postoperative complications. IOPs were measured by Goldmann applanation tonometry. The preoperative IOP was the average IOPs taken within 2 months pre-operatively. Anterior chamber inflammation was quantified as a flare value using a flare metre (FM-600, Kowa, Tokyo, Japan). The mean corneal ECD of each eye was measured using a noncontact specular microscope (NSP-9900 II, Konan, Nishinomiya, Japan) in five regions (central, superior, inferior, nasal and temporal). The type of glaucoma medications patients used preoperatively or postoperatively were prostaglandin, β-blocker, carbonic anhydrase inhibitor, brimonidine tartrate and ripasudil. The postoperative complications included frequency of hyphema, transient IOP elevation, macular edema and ciliochoroidal detachment. Transient IOP elevation was defined as an increase in IOP of 10 mmHg or more from baseline within 1 month postoperatively. Hyphema size larger than 1 mm was considered significant